These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8123471)

  • 1. Rapid detection of prognostic genetic factors in neuroblastoma using fluorescence in situ hybridisation on tumour imprints and bone marrow smears. United Kingdom Children's Cancer Study Group.
    Taylor CP; McGuckin AG; Bown NP; Reid MM; Malcolm AJ; Pearson AD; Sheer D
    Br J Cancer; 1994 Mar; 69(3):445-51. PubMed ID: 8123471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group.
    Taylor CP; Bown NP; McGuckin AG; Lunec J; Malcolm AJ; Pearson AD; Sheer D
    Br J Cancer; 2000 Jul; 83(1):40-9. PubMed ID: 10883666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children.
    Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
    Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
    Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events?
    Trakhtenbrot L; Cohen N; Betts DR; Niggli FK; Amariglio N; Brok-Simoni F; Rechavi G; Meitar D
    Cancer Genet Cytogenet; 2002 Sep; 137(2):95-101. PubMed ID: 12393279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
    Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
    Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines.
    Van Roy N; Laureys G; Cheng NC; Willem P; Opdenakker G; Versteeg R; Speleman F
    Genes Chromosomes Cancer; 1994 Jun; 10(2):103-14. PubMed ID: 7520263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of numerical and structural aberrations of chromosome 1 in neuroblastoma by interphase fluorescence in situ hybridization. Comparison with restriction fragment length polymorphism and conventional cytogenetic analyses.
    Combaret V; Turc-Carel C; Thiesse P; Rebillard AC; Frappaz D; Haus O; Philip T; Favrot MC
    Int J Cancer; 1995 Apr; 61(2):185-91. PubMed ID: 7705946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
    Ambros PF; Ambros IM; Strehl S; Bauer S; Luegmayr A; Kovar H; Ladenstein R; Fink FM; Horcher E; Printz G
    Eur J Cancer; 1995; 31A(4):510-5. PubMed ID: 7576955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
    Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
    Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
    Queizán A; García-Miguel P; Belló MJ; Castresana JC; Rey JA; Pestaña A
    Cir Pediatr; 1995 Jul; 8(3):96-8. PubMed ID: 8527322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
    Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
    N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections.
    Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J
    Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.
    Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P
    Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.
    Godfried MB; Veenstra M; Valent A; Sluis Pv; Voûte PA; Versteeg R; Caron HN
    Eur J Cancer; 2002 Jul; 38(11):1513-9. PubMed ID: 12110498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.